Embecta

Embecta EBIT CAGR 10Y

EBIT CAGR (10 Year) of Embecta (EMBC) as of Oct 18, 2026.

EBIT CAGR 10Y

-

Last updated:

EBIT CAGR (10 Year) of Embecta is 2026 - . EBIT CAGR (10 Year) of Embecta was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Embecta Stock analysis

What does Embecta do? Embecta Corp, headquartered in Parsippany, New Jersey, operates in the Health Care sector, manufacturing and distributing medical devices for diabetes treatment. The company employs 1,850 full-time staff and offers a portfolio including pen needles, syringes, safety injection devices, and a digital application for diabetes management. Its products, such as sterile single-use pen needles and safety pen needles with automatic shields, are designed to enhance user safety and convenience. Embecta distributes through retail, hospital, pharmacy, and institutional channels. Embecta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Embecta stock

On Eulerpool you can find the complete historical development of EBIT CAGR (10 Year) Embecta since 2006 – with annual values, charts, and detailed analysis.

The 10-year EBIT CAGR shows the long-term compound annual growth rate of operating earnings.

To evaluate EBIT CAGR (10 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (10 Year).

EBIT CAGR (10 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (10 Year)'s Embecta historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Embecta

All Key Metrics — Embecta